PancreatinThird Party Manufacturing in India

Pancreatin is a concentrated mixture of pancreatic enzymes obtained from porcine pancreas, containing standardized amounts of protease, amylase, and lipase. It functions as pancreatic enzyme replacement therapy by replenishing deficient endogenous pancreatic enzymes in patients with exocrine pancreatic insufficiency. The lipase component hydrolyzes dietary triglycerides into fatty acids and monoglycerides, a critical step for fat absorption that cannot be bypassed by other digestive mechanisms. The protease component, comprising trypsin and chymotrypsin, cleaves dietary proteins into peptides and amino acids. The amylase component breaks down complex starches and glycogen into maltose, maltotriose, and limit dextrins. The 300mg capsule formulation delivers these enzymes directly to the small intestine where they are released at the optimal pH for maximum activity. Minimicrospheres technology further enhances enzyme distribution by ensuring uniform mixing with chyme and preventing premature enzyme inactivation in the acidic stomach environment, thereby improving therapeutic efficacy and reducing the capsule burden per meal.

Therapeutic Uses

Pancreatin is prescribed for the treatment of:

• Exocrine Pancreatic Insufficiency (EPI): The primary indication, caused by chronic pancreatitis, cystic fibrosis, pancreatic cancer, pancreatic surgery, or Shwachman-Diamond syndrome. The 300mg capsule strength provides effective enzyme replacement for moderate to severe EPI.
• Steatorrhea: Helps manage fatty, loose stools associated with fat malabsorption, improving stool consistency and reducing stool frequency and urgency.
• Post-Pancreatectomy Digestion: Essential for patients who have undergone partial or total pancreatectomy and cannot produce sufficient endogenous pancreatic enzymes.
• Cystic Fibrosis: High-dose pancreatic enzyme replacement is critical for maintaining nutritional status and growth in paediatric and adult cystic fibrosis patients.
• Chronic Pancreatitis: Manages maldigestion and malnutrition in patients with advanced chronic pancreatitis and reduced pancreatic function.
• Pancreatic Cancer: Supports nutritional maintenance in patients with pancreatic tumours causing ductal obstruction or parenchymal destruction.

Why Manufacturers Choose Pancreatin

Pancreatin is one of the most prescribed digestive enzyme therapies worldwide, with consistent demand across both pharmaceutical and nutraceutical markets. The 300mg capsule formulation, particularly with minimicrospheres technology, represents a value-added manufacturing opportunity that commands higher margins than standard tablets. India is a major manufacturing hub for pancreatin, with established API manufacturers producing the enzyme complex from porcine pancreas under WHO-GMP conditions. The growing prevalence of pancreatic disorders, increasing awareness of EPI, and expanding geriatric population contribute to consistent demand growth. PCD franchise partners prefer pancreatin capsules for their year-round stable demand, and export opportunities to Africa, Southeast Asia, and the Middle East are expanding steadily.